The Game Changer in Shockwave Therapy
Join our Exclusive Webinar for the Launch of the New DolorClast® Focused Shockwaves
Hosted by Prof. Christoph Schmitz (LMU Munich)
Live Patient Demo with Dr. James Ferrie
Interactive Q&A
Prof Christoph Schmitz and Dr James Ferrie explore the transformative power of the new DolorClast® Focused Shockwave Device - setting a new standard in MSK care with unmatched precision, faster recovery, and superior outcomes.
Be among the first to experience the new Focused DolorClast® Shockwave Device, designed to set a new standard in MSK care. With unmatched precision, faster recovery, and superior outcomes, it surpasses its predecessor and outshines every other focused device on the market.
What You’ll Learn:
- The Science Behind Shockwave – Why precision, pressure, and energy levels matter
- Radial vs. Focused Shockwave Therapy – Stand-alone applications and use in combination
- Expanded Indications – How Focused Shockwave addresses Men’s Health & Chronic Pelvic Pain Syndrome
- Live Q&A: Ask the experts, gain practical insights, and enhance your practice
Don’t miss this chance to integrate the full DolorClast® suite into your practice—clinically, successfully, and profitably.
CPD Download will be available after the Live Stream has ended.
Date
- 16 Apr 2025
Time
AEST- 7:00 pm - 8:30 pm
Location
Trainer/Speaker
-
Prof Christoph Schmitz
-
Prof Dr Christoph Schmitz, MD, holds Chair II at the Department of Anatomy, Ludwig Maximilian University of Munich. He is a scientific advisor for the "Sportärztezeitung" and the scientific director of the continuing education series "Shockwave Therapy & Complementary Methods." In addition to his research on changes in the brain of patients with schizophrenia and autism, Prof Schmitz is deeply involved in researching the treatment of various conditions of the musculoskeletal system using extracorporeal shockwave therapy (ESWT) and, more recently, autologous stem cells. Currently, nearly 200 of his publications are indexed in PubMed. Two of his publications on ESWT for plantar fasciitis and knee osteoarthritis have received the highest rating ever achieved for ESWT studies in the PEDro database, with 9 out of 10 possible points.